Tuesday, June 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Inter Parfums Shares Face Pressure as Analysts Adjust Outlook

Robert Sasse by Robert Sasse
September 11, 2025
in Analysis, Consumer & Luxury, Earnings
0
Inter Parfums Stock
0
SHARES
164
VIEWS
Share on FacebookShare on Twitter

Fragrance and cosmetics company Inter Parfums finds itself navigating turbulent market conditions following a series of analyst downgrades and disappointing quarterly results. The stock has entered a discernible downward trajectory, marked by notable price declines and revised projections from financial institutions.

Market Experts Apply the Brakes

Equity research firm Oddo BHF recently adjusted its position on Inter Parfums, reducing its price target from €38 to €34. While the firm maintained its “Neutral” rating on the stock, this revision contributed to an immediate 3.8% drop in the share price. This analyst action was precipitated by interim financial results indicating a softening in business volumes. Since the start of the year, the stock has declined by 13.5%.

A more optimistic counterpoint comes from Berenberg, which reaffirmed its “Buy” recommendation with a €43 price objective. Their analysts acknowledged headwinds for the second half of the year, citing increased tariff expenses and a less favorable US dollar exchange rate. However, they emphasized the company’s underlying strengths, including a powerful brand portfolio, minimal debt levels, and a consistent management team.

Second Quarter Performance Falls Short of Forecasts

The company’s financial results for the second quarter of its 2025 fiscal year failed to meet market expectations. Earnings per share (EPS) came in at $0.99, significantly below the consensus forecast of $1.21. Revenue also missed the mark, reaching $334 million against projections of $357.56 million. This earnings announcement triggered a further 2.07% decrease in the stock’s value.

Should investors sell immediately? Or is it worth buying Inter Parfums?

Despite these setbacks, several positive indicators emerged from the report:
* The gross margin expanded by 170 basis points to a healthy 66.2%
* Year-to-date operating income saw a modest 1% increase
* Net sales for the first six months climbed 1% to $673 million

A regional breakdown reveals a mixed performance. European sales grew by 6% in the quarter, fueled by robust demand for key brands such as Lacoste (+59%) and Coach (+42%). In stark contrast, sales in the US market contracted by 20%, a drop primarily attributed to the termination of the Dunhill fragrance license.

Maintaining Guidance with a Focus on Holiday Sales

In spite of recent challenges, Inter Parfums’ leadership has reaffirmed its full-year guidance for 2025, projecting revenue of $1.51 billion and EPS of $5.35. The company’s strategy hinges on leveraging its established brands, launching new product innovations, and capitalizing on the critical year-end holiday shopping season. A major initiative includes the launch of its new proprietary brand, Solférino, which will feature a line of ten niche fragrances.

Governance Changes with Board Expansion

During a recent shareholder meeting, investors approved a proposal to increase the size of the company’s supervisory board from nine to eleven members. This expansion welcomes two new appointees: Patrick Bousquet-Chavanne, who brings 35 years of consumer goods expertise, and Hervé Bouillonnec, the Chief Commercial Officer of Interparfums USA.

Ad

Inter Parfums Stock: Buy or Sell?! New Inter Parfums Analysis from June 23 delivers the answer:

The latest Inter Parfums figures speak for themselves: Urgent action needed for Inter Parfums investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 23.

Inter Parfums: Buy or sell? Read more here...

Tags: Inter Parfums
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

FALLBACK Stock
Analysis

Half of German Workers Eye Early Retirement as Demographic Shift Intensifies Labor Crunch

June 23, 2026
FALLBACK Stock
Analysis

From Travel Time to Mass Layoffs: European Courts Reshape Employer Obligations Across Borders

June 22, 2026
SPACE EXPLORATION TECHN-CL A Stock
Analysis

SpaceX’s $20 Billion Bond and $60 Billion AI Bet: A Test of Investor Conviction Amid ESG Doubts

June 22, 2026
Next Post
Overstock Stock

Rebranding Raises Questions About Bed Bath & Beyond's Future Direction

Daqo New Energy Stock

Analyst Confidence Soars for Daqo New Energy Despite Quarterly Loss

Certara Stock

Can Certara's Market Leadership in Biosimulation Spark a Stock Revival?

Recommended

Fair Isaac Stock

Fair Isaac Approaches Critical Earnings Report

8 months ago
CME stock news

Navigating Uncertainty: Analysts Provide Mixed Recommendations for Getinge AB amidst Market Volatility

3 years ago
Software-solutions-technology

MongoDB Stock Plummets on Bleak Q1 and FY25 Projections

2 years ago
Vicarious Surgical Stock

Vicarious Surgical Faces Setback as Human Trials for Surgical Robot Are Delayed

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Antitrust Gridlock Hits Ams Osram: Shares Slide 6.4% as Infineon Deal Stalls — Debt Refinancing Progress Softens the Blow

Nvidia’s Vera Rubin Launch Arrives as Sovereign AI Revenue Triples to $30 Billion

Half of German Workers Eye Early Retirement as Demographic Shift Intensifies Labor Crunch

Investor Faith and Doubt Collide as Alphabet Balances Berkshire’s $10 Billion Bet Against a Talent Exodus

DAX Pulls Back From Record Range as Asian Tech Rout and Index Mechanics Upend Sentiment

Silver Price Collapse Accelerates: $62.59 as Hawkish Fed and Thawing Tensions Trump Widening Deficit

Trending

Western Digital Stock
AI & Quantum Computing

Downgrade Triggers Sharp Pullback in Western Digital’s AI-Fueled Surge

by SiterGedge
June 23, 2026
0

Western Digital’s torrid run hit a sudden roadblock on Tuesday after Fox Advisors lowered its rating on...

Keel Stock

Keel Infrastructure Bets on a Power-Landlord Model as AI Demand Strains the Grid

June 23, 2026
Hochtief Stock

Hochtief’s Narrow Free Float Exacerbates Post-DAX Profit-Taking as AI and Nuclear Ambitions Swell

June 23, 2026
Ams Osram Stock

Antitrust Gridlock Hits Ams Osram: Shares Slide 6.4% as Infineon Deal Stalls — Debt Refinancing Progress Softens the Blow

June 23, 2026
Nvidia Stock

Nvidia’s Vera Rubin Launch Arrives as Sovereign AI Revenue Triples to $30 Billion

June 23, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Downgrade Triggers Sharp Pullback in Western Digital’s AI-Fueled Surge
  • Keel Infrastructure Bets on a Power-Landlord Model as AI Demand Strains the Grid
  • Hochtief’s Narrow Free Float Exacerbates Post-DAX Profit-Taking as AI and Nuclear Ambitions Swell

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com